Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomised trial
Resource Type
Article
Authors
Yoshikawa, Takaki ; Terashima, Masanori ; Mizusawa, Junki ; Nunobe, Souya ; Nishida, Yasunori ; Yamada, Takanobu ; Kaji, Masahide ; Fukushima, Norimasa ; Hato, Shinji ; Choda, Yasuhiro ; Yabusaki, Hiroshi ; Yoshida, Kazuhiro ; Ito, Seiji ; Takeno, Atsushi ; Yasuda, Takashi ; Kawachi, Yasuyuki ; Katayama, Hiroshi ; Fukuda, Haruhiko ; Boku, Narikazu ; Sano, Takeshi ; Sasako, Mitsuru
Source
In The Lancet Gastroenterology & Hepatology March 2019 4(3):208-216
Subject
Primary Research Articles
Language
ISSN
2468-1253